In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy

NCT01976780 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

118

Enrollment

FED

Sponsor class

Conditions

Malaria

Interventions

DRUG: Artesunate
DRUG: Artemether Lumefantrine
DRUG: Mefloquine

Sponsor

Global Emerging Infections Surveillance and Response System

Collaborators

[object Object]
[object Object]